NEW PHARMACEUTICALS. HOW CAN INNOVATIVENESS?
The article describes the basic approaches to evaluating innovativeness of pharmaceuticals, Russian and foreign experience is represented. The authors pay particular attention to the state involvement in the promotion of new products and create regulatory systems for quality control. The issues of c...
Saved in:
| Main Authors: | V.V. Omel'yanovskii, M.V. Sura, N.D. Sveshnikova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2011-08-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/1239 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ANALYSIS OF THE COST OF THE DISEASE — PROBLEMS AND SOLUTIONS
by: V.V. Omel'yanovskii, et al.
Published: (2011-06-01) -
STAGES OF DEVELOPMENT OF THE ACCESS OF NEW MEDICATIONS AND HEALTH TECHNOLOGIES (Retracted)
by: V.V. Omel'yanovskii, et al.
Published: (2011-12-01) -
HEALTH TECHNOLOGY ASSESSMENT: INTERNATIONAL EXPERIENCE
by: M.V. Avksent'eva, et al.
Published: (2011-03-01) -
Review of the current approaches to the assessment of the drug innovative potential worldwide
by: N. Z. Musina, et al.
Published: (2017-11-01) -
PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS
by: Alana Viktorovna Dzaneva, et al.
Published: (2015-09-01)